NO961180D0 - Transdermal device containing (E) -2- (p-fluorophenethyl) -3-fluoroallylamine for the treatment of Alzheimer's disease - Google Patents

Transdermal device containing (E) -2- (p-fluorophenethyl) -3-fluoroallylamine for the treatment of Alzheimer's disease

Info

Publication number
NO961180D0
NO961180D0 NO961180A NO961180A NO961180D0 NO 961180 D0 NO961180 D0 NO 961180D0 NO 961180 A NO961180 A NO 961180A NO 961180 A NO961180 A NO 961180A NO 961180 D0 NO961180 D0 NO 961180D0
Authority
NO
Norway
Prior art keywords
fluoroallylamine
fluorophenethyl
alzheimer
disease
treatment
Prior art date
Application number
NO961180A
Other languages
Norwegian (no)
Other versions
NO961180L (en
Inventor
Ian Alexander Mcdonald
Michael Gavin Palfreyman
Daniel Hong-Shou Yu
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO961180D0 publication Critical patent/NO961180D0/en
Publication of NO961180L publication Critical patent/NO961180L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO961180A 1993-09-24 1996-03-22 Transdermal device containing (E) -2- (p-fluorophenethyl) -3-fluoroallylamine for the treatment of Alzheimer's disease NO961180L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12719093A 1993-09-24 1993-09-24
PCT/US1994/009517 WO1995008325A1 (en) 1993-09-24 1994-08-23 Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine for the treatment of alzheimer's disease

Publications (2)

Publication Number Publication Date
NO961180D0 true NO961180D0 (en) 1996-03-22
NO961180L NO961180L (en) 1996-03-22

Family

ID=22428772

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961180A NO961180L (en) 1993-09-24 1996-03-22 Transdermal device containing (E) -2- (p-fluorophenethyl) -3-fluoroallylamine for the treatment of Alzheimer's disease

Country Status (10)

Country Link
EP (1) EP0720475A1 (en)
JP (1) JPH09505276A (en)
CN (1) CN1131390A (en)
AU (1) AU684545B2 (en)
CA (1) CA2172605A1 (en)
HU (1) HUT75877A (en)
IL (1) IL111017A0 (en)
NO (1) NO961180L (en)
WO (1) WO1995008325A1 (en)
ZA (1) ZA947262B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100479405B1 (en) * 2002-05-24 2005-03-30 주식회사 싸이제닉 Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease
WO2010033045A1 (en) * 2008-09-16 2010-03-25 Igor Anatolievich Pomytkin Compositions and methods for prevention or treatment of beta amyloid deposition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
JPH07507299A (en) * 1992-05-27 1995-08-10 メレルダウファーマスーティカルズ　インコーポレイテッド Use of (E)-2-(p-fluorophenethyl)-3-fluoroallylamine in the treatment of Alzheimer's disease

Also Published As

Publication number Publication date
AU684545B2 (en) 1997-12-18
WO1995008325A1 (en) 1995-03-30
AU7636494A (en) 1995-04-10
EP0720475A1 (en) 1996-07-10
CA2172605A1 (en) 1995-03-30
JPH09505276A (en) 1997-05-27
ZA947262B (en) 1995-05-23
IL111017A0 (en) 1994-11-28
CN1131390A (en) 1996-09-18
HUT75877A (en) 1997-05-28
HU9600725D0 (en) 1996-05-28
NO961180L (en) 1996-03-22

Similar Documents

Publication Publication Date Title
FI962557A (en) Use of PLA2 inhibitors for the treatment of Alzheimer's disease
NO944928D0 (en) Methods for inhibiting Alzheimer's disease
NO981911D0 (en) Use of rhodanine derivatives for the manufacture of a medicament for the treatment of Alzheimer's disease
KR890701107A (en) Compounds for the treatment of Alzheimer's disease
HUP0003852A3 (en) Use of highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
ITMI951746A0 (en) DEVICE FOR THE TREATMENT OF DISPERSIONS
FI953915A0 (en) For the relief of Dupuytren's disease
NO20001869L (en) Procedure for the treatment of Alzheimer's disease
NO953254D0 (en) Substituted azolone derivatives for the treatment of helicobacter diseases
BR9711225A (en) Transdermal propentophylline compositions for the treatment of alzheimer's disease
IT1277461B1 (en) PROCEDURE AND DEVICE FOR THE TREATMENT OF MATERIALS
ITMI911096A1 (en) SYNTHESIS COMPOUNDS FOR USE IN THE TREATMENT OF RHINOVIRUS INFECTIONS
IL117695A0 (en) Pharmaceutical agents for the treatment of alzheimer's disease
ITMI931181A1 (en) PROCEDURE FOR ADDITIONAL SALCICCE TREATMENT
NO961180D0 (en) Transdermal device containing (E) -2- (p-fluorophenethyl) -3-fluoroallylamine for the treatment of Alzheimer's disease
NO982562D0 (en) Composition for the treatment of pain
ITMI912082A0 (en) MACHINE FOR HANDLING AND TREATMENT OF UPPERS
FI952953A (en) Substances for the treatment of metabolic skeletal disorders
NO944524L (en) Use of (E) -2- (p-fluorophenethyl) -3-fluoroallylamine in the treatment of Alzheimer's disease
NO953072D0 (en) Use of inhibitors of ornithine aminotransferase for the manufacture of a medicament for the treatment of Alzheimer's disease
ITBG910005U1 (en) DEVICE FOR THE RAPID APPLICATION OF SHOE COVERS
DE69404370D1 (en) Gelatinase A for the treatment of Alzheimer's disease
ITMI920106A0 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING MELATONIN OR ITS DERIVATIVE-AGONIST SUITABLE FOR THE TREATMENT OF CEREBRO-VASCULAR DISORDERS
SE9300795D0 (en) NEW PRINCIPLE FOR PAIN TREATMENT
DK8893D0 (en) MEDICAMENT FOR TREATMENT OR PREVENTION OF DISEASE